Why Are Analysts So Bullish On This Tumbling Biotech Company? By: Benzinga via Benzinga February 08, 2016 at 10:32 AM EST In the past month, shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have plummeted more than 45 percent. Granted that the biotech ... Read More >> Related Stocks: Acadia Pharmaceutica S&P Biotech SPDR